Terms: = Breast cancer AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Diagnosis
199 results:
1. Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative breast cancer.
Gardi N; Chaubal R; Parab P; Pachakar S; Kulkarni S; Shet T; Joshi S; Kembhavi Y; Chandrani P; Quist J; Kowtal P; Grigoriadis A; Sarin R; Govindarajan R; Gupta S
Cancer Res Commun; 2024 Feb; 4(2):404-417. PubMed ID: 38315150
[TBL] [Abstract] [Full Text] [Related]
2. Temporal Pattern and Age-Period-Cohort Analysis of breast cancer Incidence in Iranian Women (2009-2017).
Eslahi M; Roshandel G; Khanjani N
Arch Iran Med; 2023 Jun; 26(6):285-289. PubMed ID: 38310428
[TBL] [Abstract] [Full Text] [Related]
3. breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018.
Ghasemi-Kebria F; Fazel A; Semnani S; Etemadi A; Naeimi-Tabiei M; Hasanpour-Heidari S; Salamat F; Jafari-Delouie N; Sedaghat S; Sadeghzadeh H; Akbari M; Mehrjerdian M; Weiderpass E; Roshandel G; Bray F; Malekzadeh R
Cancer Epidemiol; 2024 Apr; 89():102525. PubMed ID: 38228040
[TBL] [Abstract] [Full Text] [Related]
4. Variation in patterns of second primary malignancies across U.S. race and ethnicity groups: a Surveillance, Epidemiology, and End Results (SEER) analysis.
McGuire V; Lichtensztajn DY; Tao L; Yang J; Clarke CA; Wu AH; Wilkens L; Glaser SL; Park SL; Cheng I
Cancer Causes Control; 2024 May; 35(5):799-815. PubMed ID: 38206498
[TBL] [Abstract] [Full Text] [Related]
5. Immune characteristics and clinical significance of peripheral blood lymphocytes in breast cancer.
Gao H; Ouyang D; Guan X; Xu J; Chen Q; Zeng L; Pang J; Zou Q; Qian K; Yi W
BMC Cancer; 2024 Jan; 24(1):50. PubMed ID: 38195475
[TBL] [Abstract] [Full Text] [Related]
6. Second primary cancers among females with a first primary breast cancer: a population-based study in Northern Portugal.
Gonçalves E; Fontes F; Rodrigues JR; Calisto R; Bento MJ; Lunet N; Morais S
Breast Cancer Res Treat; 2024 Apr; 204(2):367-376. PubMed ID: 38151690
[TBL] [Abstract] [Full Text] [Related]
7. Correlation between second and first primary cancer: systematic review and meta-analysis of 9 million cancer patients.
Wang X; Zeng M; Ju X; Lin A; Zhou C; Shen J; Liu Z; Tang B; Cheng Q; Wang Y; Zhang J; Luo P
Br J Surg; 2024 Jan; 111(1):. PubMed ID: 38055899
[TBL] [Abstract] [Full Text] [Related]
8. Circulating miRNAs signature on breast cancer: the MCC-Spain project.
Gómez-Acebo I; Llorca J; Alonso-Molero J; Díaz-Martínez M; Pérez-Gómez B; Amiano P; Belmonte T; Molina AJ; Burgui R; Castaño-Vinyals G; Moreno V; Molina-Barceló A; Marcos-Gragera R; Kogevinas M; Pollán M; Dierssen-Sotos T
Eur J Med Res; 2023 Nov; 28(1):480. PubMed ID: 37925534
[TBL] [Abstract] [Full Text] [Related]
9. Temporal Trend in Uptake of the National General Health Checkups and cancer Screening Program among Korean Women with breast cancer.
Tran TXM; Kim S; Cha C; Park B
Cancer Res Treat; 2024 Apr; 56(2):522-530. PubMed ID: 37905311
[TBL] [Abstract] [Full Text] [Related]
10. Fin field-effect-transistor engineered sensor for detection of MDA-MB-231 breast cancer cells: A switching-ratio-based sensitivity analysis.
Kumar B; Chaujar R
Phys Rev E; 2023 Sep; 108(3-1):034408. PubMed ID: 37849201
[TBL] [Abstract] [Full Text] [Related]
11. ABERRANT METHYLATION OF cancer-RELATED GENES IN VIETNAMESE breast cancer PATIENTS: ASSOCIATIONS WITH CLINICOPATHOLOGICAL FEATURES.
Dieu Vuong L; Ngoc Nguyen Q
Exp Oncol; 2023 Oct; 45(2):195-202. PubMed ID: 37824772
[TBL] [Abstract] [Full Text] [Related]
12. breast cancer screening and diagnosis in older adults women in Brazil: why it is time to reconsider the recommendations.
Rocha AFBM; Freitas-Junior R; Soares LR; Ferreira GLR
Front Public Health; 2023; 11():1232668. PubMed ID: 37601214
[TBL] [Abstract] [Full Text] [Related]
13. Examining the effectiveness of a deep learning-based computer-aided breast cancer detection system for breast ultrasound.
Fujioka T; Kubota K; Hsu JF; Chang RF; Sawada T; Ide Y; Taruno K; Hankyo M; Kurita T; Nakamura S; Tateishi U; Takei H
J Med Ultrason (2001); 2023 Oct; 50(4):511-520. PubMed ID: 37400724
[TBL] [Abstract] [Full Text] [Related]
14. Germline variants of uncertain significance, their frequency, and clinico-pathological features in a cohort of Sri Lankan patients with hereditary breast cancer.
Gunawardena K; Sirisena ND; Anandagoda G; Neththikumara N; Dissanayake VHW
BMC Res Notes; 2023 Jun; 16(1):95. PubMed ID: 37277882
[TBL] [Abstract] [Full Text] [Related]
15. Survival in elderly patients with breast cancer with and without autoimmune disease.
Dedousis D; Zhang AL; Vassiliou AN; Cao S; Yammani D; Kyasaram RK; Shanahan JP; Keinath MC; Hsu ML; Fu P; Dowlati A; Montero AJ
Cancer Med; 2023 Jun; 12(12):13086-13099. PubMed ID: 37102221
[TBL] [Abstract] [Full Text] [Related]
16. Comparison of prone and upright, stereotactic, and tomosynthesis-guided biopsies with secondary analysis of ultrasound-occult architectural distortions.
Cohen EO; Korhonen KE; Sun J; Leung JWT
Eur Radiol; 2023 Sep; 33(9):6189-6203. PubMed ID: 37042980
[TBL] [Abstract] [Full Text] [Related]
17. Study on breast cancer in Kazakhstan Using the Functional Time Series.
Shertaeva A; Ospanova D; Grjibovsky A; Shamsutdinova A; Rakhmetov N; Dushimova Z; Salimgereeva B; Yermentayeva Z; Kaketaeva I; Kuandykov Y; Tanabayeva S; Fakhradiyev I; Zharmenov S
Asian Pac J Cancer Prev; 2023 Mar; 24(3):1037-1046. PubMed ID: 36974559
[TBL] [Abstract] [Full Text] [Related]
18. Food processing and cancer risk in Europe: results from the prospective EPIC cohort study.
Kliemann N; Rauber F; Bertazzi Levy R; Viallon V; Vamos EP; Cordova R; Freisling H; Casagrande C; Nicolas G; Aune D; Tsilidis KK; Heath A; Schulze MB; Jannasch F; Srour B; Kaaks R; Rodriguez-Barranco M; Tagliabue G; Agudo A; Panico S; Ardanaz E; Chirlaque MD; Vineis P; Tumino R; Perez-Cornago A; Andersen JLM; Tjønneland A; Skeie G; Weiderpass E; Monteiro CA; Gunter MJ; Millett C; Huybrechts I
Lancet Planet Health; 2023 Mar; 7(3):e219-e232. PubMed ID: 36889863
[TBL] [Abstract] [Full Text] [Related]
19. Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England.
Gannon MR; Park MH; Miller K; Dodwell D; Horgan K; Clements K; Medina J; Cromwell DA
Cancer Epidemiol; 2023 Apr; 83():102337. PubMed ID: 36774694
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of Circ_0000977-Mediated Regulatory Network in breast cancer: A Potential Discriminative Biomarker for Triple-Negative Tumors.
Darbeheshti F; Mansoori Y; Azizi-Tabesh G; Zolfaghari F; Kadkhoda S; Rasti A; Rezaei N; Shakoori A
Biochem Genet; 2023 Aug; 61(4):1487-1508. PubMed ID: 36645554
[TBL] [Abstract] [Full Text] [Related]
[Next]
